Arterial Changes Due to Chemoembolization of Hepatocellular Carcinoma Impacting Subsequent Radioembolization

J Vasc Interv Radiol. 2016 Sep;27(9):1451-1453. doi: 10.1016/j.jvir.2016.04.029.

Authors

Pooja Patel¹, Hearns W Charles¹, James Park², Amy R Deipolyi¹

Affiliations

¹ Division of Vascular and Interventional Radiology, Department of Radiology, New York University Medical Center, 660 First Ave., 7th Floor, New York, NY 10016.
² New York University Hepatology Associates, New York University Medical Center, 660 First Ave., 7th Floor, New York, NY 10016.

PMID: 27566429
DOI: 10.1016/j.jvir.2016.04.029

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antibiotics, Antineoplastic / administration & dosage*
Antibiotics, Antineoplastic / adverse effects
Carcinoma, Hepatocellular / blood supply
Carcinoma, Hepatocellular / pathology
Carcinoma, Hepatocellular / therapy*
Chemoembolization, Therapeutic / adverse effects
Chemoembolization, Therapeutic / methods*
Collateral Circulation / drug effects
Computed Tomography Angiography
Cone-Beam Computed Tomography
Doxorubicin / administration & dosage*
Doxorubicin / adverse effects
Embolization, Therapeutic / methods*
Female
Hepatic Artery / diagnostic imaging
Hepatic Artery / drug effects*
Hepatic Artery / physiopathology
Humans
Liver Circulation* / drug effects
Liver Neoplasms / blood supply
Liver Neoplasms / pathology
Liver Neoplasms / therapy*
Neoplasm, Residual
Radiopharmaceuticals / administration & dosage*
Regional Blood Flow
Retreatment
Treatment Outcome
Yttrium Radioisotopes / administration & dosage*

Substances

Antibiotics, Antineoplastic
Radiopharmaceuticals
Yttrium Radioisotopes
Doxorubicin